PetVivo signs exclusive sales, marketing agreement with VetStem

PetVivo (PETV) Holdings has entered into an Exclusive License and Supply Agreement with VetStem to commercialize VetStem’s innovative allogeneic orthobiologic products, PrecisePRP canine and PrecisePRP equine. “This is a game changer for veterinarians and their ability to treat their patients with PRP”, said Mike Eldred, PetVivo Board Member. “This innovative, and FDA reviewed product, will be a great addition to Spryng with OsteoCushion(TM) technology, and supports our strategy to be the leader in veterinary medical devices and regenerative medicine.”